Next Article in Journal
Online Blended Learning in Small Private Online Course
Next Article in Special Issue
Nanotechnology, Nanomedicine, and the Kidney
Previous Article in Journal
Genetic Deletion of Interleukin-15 Is Not Associated with Major Structural Changes Following Experimental Post-Traumatic Knee Osteoarthritis in Rats
Previous Article in Special Issue
Electrospun Nanofibrous Membranes for Tissue Engineering and Cell Growth

Nanoarchitectures in Management of Fungal Diseases: An Overview

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India
Unichem Laboratories Limited, C31-32, Meerut Road Industrial Area, Ghaziabad 201003, India
Departments of Zoology, Shri Shakti Degree College, Sankhahari, Ghatampur 209206, India
Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, 1010 West Avenue B, MSC 131, Kingsville, TX 78363, USA
Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Ludhiana 142021, India
Department of Pharmaceutics & Pharmaceutical Technology, Yarmouk University, P.O. Box 566, Irbid 21163, Jordan
Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd 8916978477, Iran
School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine BT52 1SA, UK
Biomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001 Valencia, Spain
Authors to whom correspondence should be addressed.
Academic Editor: Morgan Hamon
Appl. Sci. 2021, 11(15), 7119;
Received: 14 June 2021 / Revised: 26 July 2021 / Accepted: 28 July 2021 / Published: 31 July 2021
(This article belongs to the Special Issue Nanomaterials in Medical Engineering)
Fungal infections, from mild itching to fatal infections, lead to chronic diseases and death. Antifungal agents have incorporated chemical compounds and natural products/phytoconstituents in the management of fungal diseases. In contrast to antibacterial research, novel antifungal drugs have progressed more swiftly because of their mild existence and negligible resistance of infections to antifungal bioactivities. Nanotechnology-based carriers have gained much attention due to their magnificent abilities. Nanoarchitectures have served as excellent carriers/drug delivery systems (DDS) for delivering antifungal drugs with improved antifungal activities, bioavailability, targeted action, and reduced cytotoxicity. This review outlines the different fungal diseases and their treatment strategies involving various nanocarrier-based techniques such as liposomes, transfersomes, ethosomes, transethosomes, niosomes, spanlastics, dendrimers, polymeric nanoparticles, polymer nanocomposites, metallic nanoparticles, carbon nanomaterials, and nanoemulsions, among other nanotechnological approaches. View Full-Text
Keywords: fungal infection; nanoarchitecture carriers; drug delivery; antifungal drugs fungal infection; nanoarchitecture carriers; drug delivery; antifungal drugs
Show Figures

Figure 1

MDPI and ACS Style

Mishra, V.; Singh, M.; Mishra, Y.; Charbe, N.; Nayak, P.; Sudhakar, K.; Aljabali, A.A.A.; Shahcheraghi, S.H.; Bakshi, H.; Serrano-Aroca, Á.; Tambuwala, M.M. Nanoarchitectures in Management of Fungal Diseases: An Overview. Appl. Sci. 2021, 11, 7119.

AMA Style

Mishra V, Singh M, Mishra Y, Charbe N, Nayak P, Sudhakar K, Aljabali AAA, Shahcheraghi SH, Bakshi H, Serrano-Aroca Á, Tambuwala MM. Nanoarchitectures in Management of Fungal Diseases: An Overview. Applied Sciences. 2021; 11(15):7119.

Chicago/Turabian Style

Mishra, Vijay, Manvendra Singh, Yachana Mishra, Nitin Charbe, Pallavi Nayak, Kalvatala Sudhakar, Alaa A. A. Aljabali, Seyed H. Shahcheraghi, Hamid Bakshi, Ángel Serrano-Aroca, and Murtaza M. Tambuwala. 2021. "Nanoarchitectures in Management of Fungal Diseases: An Overview" Applied Sciences 11, no. 15: 7119.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop